Skip to main content

ABHD6 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-82552

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-82552-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the C-terminal region of Human ABHD6. Peptide sequence: MLAKSIANCQVELLENCGHSVVMERPRKTAKLIIDFLASVHNTDNNKKLD The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for ABHD6 Antibody

Western Blot: ABHD6 Antibody [NBP2-82552]

Western Blot: ABHD6 Antibody [NBP2-82552]

Western Blot: ABHD6 Antibody [NBP2-82552] - WB Suggested Anti-ABHD6 Antibody. Titration: 1.0 ug/ml. Positive Control: Fetal Heart

Applications for ABHD6 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: ABHD6

ABHD6 has 2-arachidonoylglycerol hydrolase activity . May be a regulator of endocannabinoidsignaling pathways

Long Name

Monoacylglycerol lipase ABHD6

Alternate Names

EC 3.1.1.23

Gene Symbol

ABHD6

Additional ABHD6 Products

Product Documents for ABHD6 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for ABHD6 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...